SCHEMBL4922170

SCHEMBL4922170

Clc1nc2ncnc-2c(N2CCN(c3ccc4ccccc4n3)CC2)[nH]1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
HRH3 Q9Y5N1 7/20 0.48
KDM4E B2RXH2 7/20 0.48
ALDH1A1 P00352 6/20 0.48
HTR3E A5X5Y0 2/20 0.48
HTR3B O95264 2/20 0.48
CYP1A2 P05177 2/20 0.48
HTR3A P46098 2/20 0.48
HTR3D Q70Z44 2/20 0.48
HTR3C Q8WXA8 2/20 0.48
TDP1 Q9NUW8 2/20 0.48
CYP3A4 P08684 2/20 0.48
HSD17B10 Q99714 2/20 0.48
HTR1A P08908 2/20 0.48
USP2 O75604 1/20 0.48
ADRB1 P08588 1/20 0.48
HTR2C P28335 1/20 0.48
MAPK1 P28482 1/20 0.48
SLC6A4 P31645 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4926745 0.99 NPC1 (0.48) NPC1RAB9AHRH3KDM4EALDH1A1
SCHEMBL4907107 0.82 MAPT (0.48) RAB9AKDM4EALDH1A1CYP3A4HSD17B10
SCHEMBL4913227 0.80 MAPT (0.40) NPC1RAB9AALDH1A1HTTSMN1; SMN2
SCHEMBL4908143 0.80 HTR3E (0.48) NPC1RAB9AKDM4EALDH1A1HTR3E
Hydrochloric Acid SCHEMBL4899154 0.79 MAPT (0.39) NPC1RAB9AALDH1A1HTTSMN1; SMN2
Hydrochloric Acid SCHEMBL4901792 0.79 HTR3E (0.47) NPC1RAB9AKDM4EALDH1A1HTR3E
SCHEMBL4901811 0.76 KDM4E (0.38) NPC1RAB9AKDM4EALDH1A1HTR3A
SCHEMBL4910047 0.76 ALDH1A1 (0.46) NPC1RAB9AKDM4EALDH1A1HSD17B10
SCHEMBL4908538 0.76 HPGD (0.36) NPC1RAB9AKDM4EALDH1A1CYP1A2
SCHEMBL4905049 0.75 ABCB1 (0.45) HRH3KDM4EALDH1A1TDP1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080119467-A1 Purine Derivatives, Compositions Containing Them and Use Thereof AVENTIS PHARMA S.A. (FR) 2008-05-22 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119467-A1 Purine Derivatives, Compositions Containing Them and Use Thereof TYMP, HPRT1, IMPDH1 NPC1 1908/4885RAB9A 3384/4885HRH3 3074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.